PREP smarter to unlock lasting outcomes
The evidence is clear - successful SFA treatments start with optimizing vessel preparation. With advanced technologies like Jetstream™ - our atherectomy to treat mixed morphologies - and our Balloons, we help you tackle challenging lesions, maximize luminal gain, minimize residual stenosis, optimize drug transfer, and reduce the need for bailout stenting.
PREP smarter with Jetstream™
Demonstrated a high Primary Patency of
91%
at 12 month, despite lesion length.¹
PREP smarter with Atherectomy in a DCB first strategy
Leading experts on the vascular field agree that vessel PREP is extremely important, specially in patients with complex lesions. The way a vessel is prepared conditions the late outcomes.
Clinical evidence supports that :
- Atherectomy reduces stenting and maintains benchmark patency, even in long complex lesions.
- Atherectomy positively impacts patients' outcomes.
- Smarter PREP with Jetstream achieves benchmark Patency without the need for stenting.²
Six randomized trials and a Meta-Analysis ³⁻¹⁰ backup the importance of Atherectomy in lesions with thrombotic load and severe calcification. Atherectomy as a vessel preparation tool for femoropopliteal lesions that help reducing Primary Patency and Bailout Stenting.
PREP smarter with proven preparation devices
Our advanced vessel preparation portfolio supports endovascular procedures with precision and efficiency, helping achieve optimal, long-term patient outcomes.
The power to treat it all with JETSTREAM™
Patients with Peripheral Artery Disease display a wide range of lesions. Experience the only rotational atherectomy system engineered to predictably treat them all.
Access the product page
MUSTANG™
0.035” Balloon Dilatation Catheter
Access the product page
CHARGER™
0.035” Balloon Dilatation Catheter
Access the full catalogue
STERLING™
PTA Balloon Dilatation Catheter
Access the product page
COYOTE™
0.014” Balloon Dilatation Catheter
Access the product page
ATHLETIS™
Ultra-High-Pressure Balloon
Access the full catalogue
Peripheral Cutting Balloon™
Microsurgical Dilatation Device
Access the product page
AngioJet™
Peripheral Thrombectomy System
Access the product page
ENCORE™ 40
Inflation Device
Access the full catalogue
ENCORE™ 26
Inflation Device
Access the full catalogue
Your Modern Endovascular Interventions learning journey
Explore our Endovascular Interventions Online Learning platform for free online education and find in-person training events to PREP smarter and keep vessels open for longer.
References:
1.Andrassy M, Lichtenberg M, Brodmann M, Andrassy J, Giusca S, Korosoglou G. Jetstream Rotational Atherectomy and Drug Coated Balloon Angioplasty with In Stent Re-stenosis and Occlusions. A Two Centre Study. Eur J Vasc Endovasc Surg. 2022 Dec;64(6):733-734.
2.Atherectomy in Complex Lesions: Real-World Challenges and Data presented by Martin Andrassy, MD. CIRSE 2020
3.Pan D, et al. Efficacy and Safety of Atherectomy Combined With Balloon Angioplasty vs Balloon Angioplasty Alone in Patients With Femoro-Popliteal Lesions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Endovasc Ther. 2023 Dec 4:15266028231215354. doi: 10.1177/15266028231215354. Epub ahead of print. PMID: 38049942.
4.Shammas NW, Jones-Miller S, Shammas GA, Shammas WJ. Jetstream Atherectomy in Treating Femoropopliteal In-Stent Restenosis: Meta-Analysis of the JETSTREAM-ISR and JET-ISR Trials. J Invasive Cardiol. 2020 Aug;32(8):289-294. doi: 10.25270/jic/20.00192. PMID: 32737264.
5.Cai H, Dong J, Ye Y, Song Q, Lu S. Safety and efficacy of drug-coated balloon in the treatment of below-the-knee artery: A meta-analysis. J Surg Res. 2022;278:303–316. doi:10.1016/j.jss.2022.04.055.
6.Caradu C, Lakhlifi E, Colacchio EC, et al. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg. 2019;70(3):981–995.e910. doi:10.1016/j.jvs.2019.01.080.
7.Dinh K, Limmer AM, Chen AZL, et al. Mortality rates after paclitaxel-coated device use in patients with occlusive femoropopliteal disease: An updated systematic review and meta-analysis of randomized controlled trials. J Endovasc Ther. 2021;28(5):755–777. doi:10.1177/15266028211023505.
8.Dinh K, Limmer AM, Chen AZL, et al. Mortality rates after paclitaxel-coated device use in patients with occlusive femoropopliteal disease: An updated systematic review and meta-analysis of randomized controlled trials. J Endovasc Ther. 2021;28(5):755–777. doi:10.1177/15266028211023505.
9.Pinto P, Chaar CIO. Atherectomy — the options, the evidence, and when should it be used. Ann Vasc Surg. 2024;107:127–135. doi:10.1016/j.avsg.2023.12.104.
10.Zeller T. Systematic literature review and meta-analysis on the use of atherectomy for peripheral endovascular interventions: Patient and lesion subgroup results. Presented at Charing Cross Symposium; April 24, 2025; London, UK.
Caution:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.